Nashville Biosciences
Aayush Gupta has a diverse range of work experience in various industries. In 2015, they worked as a Shadowing Position at Biocon, where they gained insight into the daily activities of professionals in pharmaceutical research and development. In 2018, they served as an Offline Marketing Intern at 1mg, where they targeted specific demographics in urban areas in India to increase app consumers. In 2019, Aayush joined the Woynoroski Lab as a Research Assistant, collecting sensory data from individuals with autism spectrum disorder and utilizing data analytics to understand sensory function in relation to social communication deficits. From 2019 to the present, they have been working at Nashville Biosciences as a Business Development Intern/Analyst, assisting with researching potential clients, identifying new service offerings, and supporting sales and marketing activities. Additionally, Aayush worked as a Private Tutor at the American Embassy School from 2013 to 2015.
Aayush Gupta pursued their Bachelor of Engineering (BE) in Biomedical Engineering from Vanderbilt University from 2016 to 2020. Prior to that, they completed their High School Diploma at The American Embassy School in New Delhi from 2012 to 2016. The field of study for their high school education is unknown.
This person is not in any offices
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.